Your browser doesn't support javascript.
loading
Radiation Therapy Skin Marking with Lancets Versus Electric Marking Pen (COMFORTATTOO)-6 Months Results on Cosmesis, Fading, and Patients' Satisfaction From a Randomized, Double-Blind Trial.
Pires, André M; Carvalho, Luísa; Santos, Ana C; Vilaça, Ana M; Coelho, Ana R; Oliveira, Celeste; Costa, Céline; Fernandes, Flávia; Moreira, Liliana; Lima, João; Vieira, Rafaela; Ferraz, Maria J; Silva, Marta; Silva, Pedro; Matias, Rafael; Zorro, Sara; Costa, Susana; Sarandão, Susana; Barros, Ana F.
Afiliación
  • Pires AM; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Carvalho L; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Santos AC; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Vilaça AM; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Coelho AR; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Oliveira C; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Costa C; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Fernandes F; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Moreira L; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Lima J; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Vieira R; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Ferraz MJ; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Silva M; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Silva P; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Matias R; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Zorro S; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Costa S; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Sarandão S; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
  • Barros AF; Radiation Oncology Department, Portuguese Institute of Oncology of Porto, R. Dr António Bernardino de Almeida, Porto, Portugal.
Adv Radiat Oncol ; 9(3): 101404, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38292889
ABSTRACT

Purpose:

Most of radiation oncology centers rely on set-up skin markings for patient setup during treatment delivery. Permanent dark-ink tattooing is the most popular marking method. COMFORTATTOO is a unicentric, randomized trial testing 2 permanent

methods:

lancets against an electric marking pen (Comfort Marker 2.0, CM). One substudy was undertaken to test if using the CM translates into a cosmesis, fading, or satisfaction benefit compared with the lancets. Methods and Materials Patients aged 18 years or older referred to our department to receive RT were recruited. They were randomly assigned, in a 11 ratio, to receive set-up markings using lancets or CM. This substudy aimed to recruit all the living participants included in the main study. The primary endpoints were tattoos cosmesis, tattoos fading, and patients' satisfaction 6 months after finishing the RT. Cosmetic and fading assessments were scored on a 5-point ascending scale and patients' satisfaction on a 10-point ascending scale. The trial is registered at ClinicalTrials.gov (number NCT05371795).

Results:

Between April and September 2022, 92 patients were enrolled (45 assigned to lancets and 47 to CM) and assessed for the outcomes. Patients receiving CM had significantly better cosmetic markings, with a median score of 4.4 (vs 3.7 for lancets, P<.001). On the fading assessment, the CM was associated with lower scores compared with the lancets (median score of 1.3 and 3.3, respectively; P<.001). No differences in patients' satisfaction were observed with either method (median score of 10 for both arms, P=.952).

Conclusions:

Our substudy results demonstrated that, 6 months after the end of RT, the CM produces better cosmetic markings with less fading compared with the lancets. These differences didn't translate into patients' satisfaction superiority toward any method.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Adv Radiat Oncol Año: 2024 Tipo del documento: Article País de afiliación: Portugal

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Adv Radiat Oncol Año: 2024 Tipo del documento: Article País de afiliación: Portugal